ArticleCureus2025
Therapeutic Efficacy and Complication Profile of Monopolar Transurethral Resection of the Prostate (TURP) in the Management of Bladder Outlet Obstruction.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Can the use of a visual obturator-assisted resectoscope reduce the incidence of urethral strictures after TURP?: a multicenter propensity-matched study.World journal of urology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBladder outlet obstruction (BOO) due to benign prostatic hyperplasia (BPH) is a common urological condition in aging men, often requiring surgical intervention for symptom relief.
objectiveTo evaluate the therapeutic efficacy and complication profile of monopolar transurethral resection of the prostate (TURP) in patients with BOO. METHODOLOGY: This descriptive observational study was conducted at the Department of Urology, Hayatabad Medical Complex, Peshawar, and Akhtar Saeed Trust Hospital, Lahore, from August 2022 to July 2024. A total of 518 male patients aged ≥ 50 years with BOO secondary to BPH underwent monopolar TURP. Preoperative, intraoperative, and postoperative variables were collected using a standardized proforma. Functional outcomes, including International Prostate Symptom Score (IPSS), maximum urinary flow rate (Qmax), and post-void residual volume (PVR), were assessed at baseline and one, six, and 12 months postoperatively. Complication rates and predictors were also analyzed.
resultsMean age was 68.42 ± 7.85 years. Significant improvement was observed in IPSS (from 23.74 ± 4.96 to 7.82 ± 2.81), Qmax (from 7.89 ± 2.11 mL/sec to 17.50 ± 4.67 mL/sec), and PVR (from 126.40 ± 34.70 mL to 30.10 ± 16.87 mL) at 12 months (p < 0.001). Early complications included hematuria in 42 patients (8.11%), UTI in 61 (11.78%), and TUR syndrome in six (1.16%). Late complications included urethral stricture (3.67%) and bladder neck contracture (2.12%).
conclusionMonopolar TURP is an effective and safe surgical option for managing BOO due to BPH in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.